947. Treatment Approaches for B-lactam-Resistant Pneumococci
Session: Symposium: How to Treat Resistant Gram-Positive Infections
Friday, October 5, 2018: 11:20 AM
Room: N 24
George Sakoulas, MD, University of California San Diego School of Medicine, San Diego, CA

George Sakoulas, MD, earned his medical degree from Harvard Medical School, Boston, Massachusetts, and completed his postgraduate training in internal medicine at Beth Israel Deaconess Medical Center in 1998, From 1998-1999 he served as chief medical resident in the Department of Medicine at Beth Israel Deaconess Medical Center. From 1999 to 2002, he was a fellow in infectious diseases at Beth Israel Deaconess Medical Center where he developed interests in Gram positive infections. He is an active infectious diseases clinician in the Sharp Healthcare System in San Diego and holds a research appointment as Associate Professor of Pediatrics at the University of California San Diego School of Medicine, Division of Host-Microbe Systems and Therapeutics. His current interests are developing novel strategies for the treatment of difficult bacterial infections in the healthcare and community setting, particularly by uncovering unrecognized properties of currently available antibiotics. He is also interesting in understanding the host immune response to infection, particularly as a risk stratification tool on which to select antimicrobial therapy


Disclosures:

G. Sakoulas, Allergan: Consultant and Speaker , Consulting fee and Speaker honorarium . Sunovion Pharmaceuticals: Speaker , Speaker honorarium . The Medicines Company: Speaker , Speaker honorarium . Paratek Pharmaceuticals: Consultant , Consulting fee . Cidara Therapeutics: Scientific Advisor , Consulting fee . Arsanis Pharmaceuticals: Scientific Advisor , Consulting fee .

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.